{
    "popularityCurve": {
        "data": [
            1
        ],
        "xLabels": [
            "00:23"
        ],
        "label": "the plan b otc switch application was the only one during this period that was not approved after the advisory committees recommended approval there are no age-related marketing restrictions for any prescription or otc contraceptives that fda has approved and fda has not required pediatric studies for them fda identified no issues that would require age-related restrictions in the review of the original prescription plan b gao found that high-level management's involvement for the plan b decision was unusual for an otc switch application and fda officials gave gao conflicting accounts about when they believed the decision was made"
    },
    "clusterList": [
        {
            "phrase": "the plan b otc switch application was the only one during this period that was not approved after the advisory committees recommended approval there are no age-related marketing restrictions for any prescription or otc contraceptives that fda has approved and fda has not required pediatric studies for them fda identified no issues that would require age-related restrictions in the review of the original prescription plan b gao found that high-level management's involvement for the plan b decision was unusual for an otc switch application and fda officials gave gao conflicting accounts about when they believed the decision was made",
            "count": 1
        }
    ]
}